FOXP3+ regulatory T cells (Tregs) act as tumor suppressors, while immunohistochemical studies demonstrate that immune cells regulate both antitumor responses and tumor-promoting conditions within the TME (23, 24). Here, FOXP3 is linked to neoplasm.